This content was created by Everyday Health Media on behalf of an advertiser.
More Information.
Content on this page was created by the Everyday Health Media team and is funded by an advertiser. The content conforms to Everyday Health Media’s editorial standards for accuracy, objectivity, and balance. The advertiser may select the specialty area but does not edit or approve the content.
RSV in Adults
Not the News We Want to Hear: Antibiotics for Adults with Viral Respiratory Infections
A study conducted with data from a single hospital in Norway suggests that healthcare systems may need to reevaluate how antibiotics are delivered to patients who present at the hospital with symptoms of a viral respiratory tract infection.
Against Respiratory Syncytial Virus: Some New Projections
Research is shedding light on the true burden of respiratory syncytial virus (RSV) on the U.S. population, especially more-vulnerable older adults. So, what sort of difference will new vaccines against RSV make?
In Hospitalized Adults With RSV, What Drives Intensive Care and Mortality?
French investigators took on the task of characterizing hospitalization in adult RSV patients, identifying factors associated with admission to the intensive care unit and mortality.
RSV in Adults: Assessing Its True Burden
A new study takes an in-depth look at the disease burden of confirmed respiratory syncytial virus-acute respiratory infections (cRSV-ARIs) in community-dwelling adults compared with that of patients in long-term care facilities.
The RSV Burden is Climbing Among Older Adults in Affluent Countries
These findings suggest that the number of respiratory syncytial virus–acute respiratory infection cases, hospitalizations, and in-hospital deaths in at-risk populations could reach 5.7 million by 2025.
.jpg)
Respiratory Syncytial Virus in Adults: An Update on Its Diagnosis and Impact
A recent analysis indicates that cough is the most common presentation of respiratory syncytial virus (RSV) in high-risk populations and, depending on which country or region of the world patients live in, symptoms may last for weeks.
RSV in Older Adults Before and After COVID: A Primary Care Analysis
A large community-based cohort study underscores the burden of infection in older populations and the potential need for, and benefits of, public health measures to curb respiratory syncytial virus (RSV).